Authors
Loading...
Observational analysis revealed enhanced cardiometabolic responses in iPSC-derived cardiomyocytes, suggesting incretin-based therapies have cardioprotective effects.
banahene et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: